AACR meeting 2016

The American Association for Research on Cancer (AACR) annual meeting took place last week in New Orleans, involving close to 20,000 participants covering academia, government organisations, charities and private industry. Quite a few Epicentre colleagues were at the AACR this year, and had some interesting post-meeting thoughts. For those who have participated in previous AACR […]

New cancer ‘moonshot’ by President Obama, and Illumina takes up early detection of cancer

This week saw the last of the State of the Union addresses by President Obama, and those of us at EPICentre were gladdened by the priority he gave to cancer. In stirring words he talked of ‘For the loved ones we have all lost, for the family we can still save, let’s make America the […]

Bad luck and cancer risk

Those of us at Epicentre have long appreciated that bad luck plays a part in the risk of getting a cancer. This conclusion seems to be unavoidable once it is understood that a cancer results from a series of genetic mutations or other deleterious genomic events that occur over time within a single cell […]

How can genomics help us understand the hidden causes of cancer

We are well used to hearing about new large-scale cancer genomics studies, and how they might provide insights into new treatments for cancer, although what is often of more interest to those of us at EPICentre is how genomics can help unravel the causes of cancer, in particular for those cancers for which traditional epidemiology […]

Good news for research into early detection of cancer

Of the 14,000,000 cancer cases that occur globally each year, over half will eventually die from their disease, usually within 5 years of diagnosis. Even though there is much excitement about new treatments for cancer that target specific genomic aspects of the tumour (so called personalised medicines) it is hard to envisage how this strategy […]